According to Fortune Business Insights, the global generative AI in healthcare market size was valued at USD 2.86 billion in 2025. The market is projected to grow from USD 3.74 billion in 2026 to USD 31.51 billion by 2034, exhibiting a compound annual growth rate (CAGR) of 30.53% during the forecast period.
Generative artificial intelligence (AI) in healthcare refers to technologies that generate text, images, synthetic data, and other outputs by learning patterns from existing information. These technologies can analyze electronic health records, medical images, clinical documentation, and genetic data to support healthcare professionals and streamline medical workflows.
The growing adoption of digital healthcare solutions, increasing demand for personalized medicine, and advancements in large language models (LLMs) are supporting market expansion. Healthcare organizations are increasingly exploring generative AI to automate administrative tasks, improve clinical documentation, assist medical research, and enhance patient engagement.
Market Size and Forecast
- 2025 Market Size: USD 2.86 billion
- 2026 Market Size: USD 3.74 billion
- 2034 Forecast Market Size: USD 31.51 billion
- CAGR (2026–2034): 30.53%
The market is expected to expand as healthcare providers and pharmaceutical companies invest in AI-powered software and services. The integration of generative AI with healthcare information systems is creating opportunities to improve operational efficiency and accelerate selected research activities.
Get a Free Sample PDF - https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/generative-artificial-intelligence-ai-in-healthcare-market-109466
Key Market Growth Drivers
Increasing Demand for Personalized Medicine
Personalized medicine uses patient-specific information, including genetic characteristics, medical history, and clinical data, to guide treatment decisions. Generative AI can help researchers analyze complex datasets, identify potential patterns, and generate insights that support individualized healthcare approaches.
These capabilities are encouraging healthcare organizations to explore AI-based tools for treatment planning, patient risk assessment, and clinical research. As precision medicine advances, demand for technologies that process complex medical information is expected to increase.
Growing Need for Healthcare Workflow Automation
Healthcare professionals often spend considerable time preparing clinical notes, reviewing patient records, and managing administrative documentation. Generative AI can assist with summarizing consultations, drafting clinical notes, organizing information, and supporting communication between healthcare teams.
Automating selected administrative activities can help reduce documentation burdens and allow clinicians to focus more time on patient care. The growing demand for efficient healthcare operations is therefore supporting adoption across hospitals and clinics.
Advancements in Drug Discovery and Development
Generative AI is gaining attention in pharmaceutical research because it can help researchers explore molecular structures, generate potential drug candidates, and analyze scientific literature. These applications may support target identification, compound screening, and early-stage drug development.
Pharmaceutical and biotechnology companies are increasingly investing in AI technologies to improve research productivity and investigate complex biological processes. However, generated findings require scientific validation and appropriate experimental testing before clinical use.
Market Segmentation
According to Fortune Business Insights, the generative AI in healthcare market is segmented by offering, application, and end-user.
By Offering: The market includes software and services. Software held a significant market share in 2023, supported by increasing adoption of AI platforms and collaborations between technology providers and healthcare organizations. These solutions support clinical documentation, patient data analysis, and workflow automation. Services are expected to grow as healthcare institutions require implementation, integration, training, and technical support.
By Application: Major applications include electronic health records, personalized medicine, disease diagnosis, drug discovery and development, and others. Electronic health records benefit from AI-assisted documentation and information summarization. Personalized medicine applications use AI to analyze patient-specific data, while disease diagnosis applications can assist clinicians in interpreting medical information. Drug discovery and development represent another important area because generative models can help researchers explore potential therapeutic candidates.
By End-User: The market includes hospitals and clinics, biopharmaceutical companies, diagnostic centers, and other organizations. Hospitals and clinics use generative AI to improve documentation, patient communication, and clinical workflows. Biopharmaceutical companies apply these technologies to research and drug development, while diagnostic centers may use AI tools to support reporting and information management.
Regional Market Insights
North America
North America accounted for a significant share of the global market in 2023. Strong technology infrastructure, established healthcare systems, and investments by leading AI developers support regional adoption. Collaborations between technology companies and healthcare providers are helping integrate generative AI into clinical and administrative workflows.
Europe
Europe is expected to experience significant market growth during the forecast period. Healthcare digitization initiatives, research collaborations, and increasing interest in AI-supported clinical operations are creating opportunities. Regulatory compliance and responsible handling of patient information remain important considerations for market participants.
Asia Pacific
Asia Pacific presents growth opportunities as healthcare providers invest in digital infrastructure and AI-powered solutions. Increasing healthcare demand, expanding biotechnology research, and technological development in China, India, and Japan are supporting adoption. Regional growth will also depend on data availability, infrastructure readiness, and the development of appropriate regulatory frameworks.
Key Market Challenges
The generative AI in healthcare market faces challenges related to patient data privacy, algorithmic bias, inaccurate outputs, and regulatory compliance. Generative models can produce misleading or unsupported information, making clinical oversight and validation essential.
Healthcare organizations must also ensure that AI systems integrate effectively with existing electronic health records and information technology infrastructure. High implementation costs, limited technical expertise, and concerns about data security may slow adoption, particularly among smaller healthcare providers.
Competitive Landscape
The global market includes technology companies, healthcare software providers, and specialized AI developers. Key players identified by Fortune Business Insights include Persistent Systems, NVIDIA Corporation, Abridge AI, Inc., ELEKS, Oracle, Syntegra, Epic Systems Corporation, DiagnaMed Holdings Corp., Insilico Medicine, and Codoxo.
Companies are focusing on product innovation, strategic partnerships, cloud-based platforms, and healthcare-specific AI models. These strategies aim to improve clinical documentation, support drug development, and expand the practical use of generative AI across healthcare organizations.
Conclusion
The global generative AI in healthcare market is projected to grow from USD 2.86 billion in 2025 to USD 31.51 billion by 2034. Increasing demand for personalized medicine, healthcare workflow automation, and AI-assisted drug discovery is expected to drive expansion. Despite challenges involving data privacy, accuracy, and regulatory compliance, continued technological innovation and responsible implementation are likely to create substantial opportunities for the industry.
Comments